Introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers
Authors
McAteer, M. A.O'Connor, James P B
Koh, D. M.
Leung, H. Y.
Doran, S. J.
Jauregui-Osoro, M.
Muirhead, N.
Brew-Graves, C.
Plummer, E. R.
Sala, E.
Ng, T.
Aboagye, E. O.
Higgins, G. S
Punwani, S.
Affiliation
Department of Oncology, University of Oxford, Oxford, UK.Issue Date
2021
Metadata
Show full item recordAbstract
The National Cancer Imaging Translational Accelerator (NCITA) is creating a UK national coordinated infrastructure for accelerated translation of imaging biomarkers for clinical use. Through the development of standardised protocols, data integration tools and ongoing training programmes, NCITA provides a unique scalable infrastructure for imaging biomarker qualification using multicentre clinical studies.Citation
McAteer MA, O’Connor JPB, Koh DM, Leung HY, Doran SJ, Jauregui-Osoro M, et al. Introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers. Br J Cancer. 2021 Jul 27Journal
British Journal of CancerDOI
10.1038/s41416-021-01497-5PubMed ID
34316019Additional Links
https://dx.doi.org/10.1038/s41416-021-01497-5Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41416-021-01497-5
Scopus Count
Collections
Related articles
- Imaging biomarker roadmap for cancer studies.
- Authors: O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC
- Issue date: 2017 Mar
- The importance of the methodology and sample matrix when interpreting chromogranin A results.
- Authors: Kavsak PA, Beattie J, Rutledge AC
- Issue date: 2019 Oct 25
- Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practice.
- Authors: Mattes WB, Goodsaid F
- Issue date: 2018 Feb
- Biomarkers for Cervical Cancer Prevention Programs: The Long and Winding Road From Discovery to Clinical Use.
- Authors: Wentzensen N, Silver MI
- Issue date: 2016 Jul
- Biomarkers in preclinical cancer imaging.
- Authors: Bernsen MR, Kooiman K, Segbers M, van Leeuwen FW, de Jong M
- Issue date: 2015 Apr